Summary of Study ST003048

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001898. The data can be accessed directly via it's Project DOI: 10.21228/M8CQ76 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST003048
Study TitleIdentification and validation of serum metabolite biomarkers for endometrial cancer diagnosis
Study TypeBiomarker, Endometrial cancer, Machine learning, Mass spectrometry, Metabolite
Study SummaryEndometrial cancer (EC) stands as the most prevalent gynecological tumor in women worldwide. Notably, differentiation diagnosis of abnormity detected by ultrasound findings (e.g., thickened endometrium or mass in the uterine cavity) is essential and remains challenging in clinical practice. Herein, we identified a metabolic biomarker panel for differentiation diagnosis of EC using machine learning of high-performance serum metabolic fingerprints (SMFs) and validated the biological function. We first recorded the high-performance SMFs of 191 EC and 204 Non-EC subjects via particle-enhanced laser desorption/ionization mass spectrometry (PELDI-MS). Then, we achieved an area-under-the-curve (AUC) of 0.957-0.968 for EC diagnosis through machine learning of high-performance SMFs, outperforming the clinical biomarker of cancer antigen 125 (CA-125, AUC of 0.610-0.684, P < 0.05). Finally, we identified a metabolic biomarker panel of glutamine, glucose, and cholesterol linoleate with an AUC of 0.901-0.902 and validated the biological function in vitro. Therefore, our work would facilitate the development of novel diagnostic biomarkers for EC in clinics.
Institute
Shanghai Jiao Tong University
DepartmentSchool of Biomedical Engineering
Last NameLiu
First NameWanshan
Address1954 Huashan Road, Shanghai, China
Emailliuwanshan@sjtu.edu.cn
Phone+86-13262629289
Submit Date2024-01-20
Analysis Type DetailMALDI
Release Date2024-01-23
Release Version1
Wanshan Liu Wanshan Liu
https://dx.doi.org/10.21228/M8CQ76
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Treatment:

Treatment ID:TR003172
Treatment Summary:NA
  logo